Analyst Ratings for Bolt Biotherapeutics, Inc. (BOLT)
BOLT Rating Summary
BOLT Price Target Summary
- Highest: $75.00 (Lake Street )
- Lowest: $6.00 (Leerink Partners)
- Average: $29.33
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$29.33 (+582.2%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
Avg. $ Target:
$29.33 (+582.2%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/20/2025 | H.C. Wainwright | Robert Burns | New Coverage | Buy (N/A) |
7.00 (N/A) |
5.75 (4.30) |
-25.22% | Details |
| 5/20/2025 | Lake Street » Updated 8/15/2025 |
Chad Messer | New Coverage | Buy (N/A) |
75.00 (4.00) |
0.33 (4.30) |
1203.03% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
